Technology

Oragenics

$0.91
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.0213 (-2.24%) Today
-$0.0187 (-2.01%) As of 1:00 AM UTC after-hours

Why Robinhood?

You can buy or sell Oragenics and other stocks, options, and ETFs commission-free!

About OGEN

Oragenics Inc., also called Oragenics, is a biopharmaceutical company, which focuses on the development of novel antibiotics and treatments against infectious disease and oral mucositis. Its technology and pipeline is comprised of antibiotics and genetically engineered bacterial strains. The company was founded by Jeffrey D. Hillman and Robert T. Zahradnik in November 1996 and is headquartered in Tampa, FL. The listed name for OGEN is Oragenics Inc.

CEO
Alan F. Joslyn
Employees
7
Headquarters
Tampa, Florida
Founded
1996
Market Cap
68.93M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
73.53M
High Today
$1.03
Low Today
$0.9015
Open Price
$0.945
Volume
30.38M
52 Week High
$2.09
52 Week Low
$0.36

Collections

OGEN Earnings

-$0.24
-$0.16
-$0.08
$0.00
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
— per share
Actual
Expected Mar 4, After Hours

You May Also Like

CAP=
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure